Back to calendar
Denali Therapeutics Inc. (DNLI) Earnings
DNLI reports earnings on Thursday, July 30, 2026
earnings report
July 30, 2026 · Before Market Open
Q2 2026
Est. EPS: $-0.71
Actual EPS: $-0.69
EPS surprise: 4.61%
Company overview
Market Cap$4.1B
PriceUSD 25.68
EPS (TTM)-2.88
52-week high27.30
52-week low12.58
SectorHealth Technology
IndustryBiotechnology
Employees503